Date published: 2025-10-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

GPR82 Activators

GPR82 is a G protein-coupled receptor (GPCR) whose activity can be affected by various agents through different mechanisms. Certain compounds are known to directly activate adenylate cyclase, increasing cyclic AMP (cAMP) concentrations within the cell. This rise in cAMP activates protein kinase A (PKA), which may phosphorylate and activate GPR82, thereby modulating its signaling cascade. Other agents function as non-selective beta-adrenergic agonists, further elevating intracellular cAMP levels through Gs protein activation and enhancing PKA-mediated phosphorylation of GPR82. Muscarinic acetylcholine receptor agonists or nicotinic receptor agonists can alter G-protein signaling in a manner that changes G-protein coupling preferences, potentially affecting GPR82's activity. Similarly, histamine, acting through its own GPCRs, can influence the cellular signaling environment and alter the activity of other GPCRs, including GPR82, through modifications in G-protein signaling dynamics.

Additional chemical agents can indirectly influence the activation of GPR82 through diverse pathways. For example, the activation of TRPV1 receptors by certain ligands leads to a calcium influx, which has extensive effects on GPCR activity, including the possible upregulation of GPR82. Antagonists of adenosine receptors can increase catecholamine release, enhancing GPCR signaling pathways and potentially activating GPR82. Moreover, alterations in prostaglandin levels due to the influence of certain anti-inflammatory drugs might impact GPR82 activity. Nitric oxide donors engaging cGMP pathways caninfluence the activation of protein kinase G (PKG), which has the potential to phosphorylate and thus modulate GPCR functions, including those of GPR82. Additionally, adrenergic receptor agonists may induce crosstalk between adrenergic signaling and other GPCR pathways, possibly enhancing GPR82 activity. Cholinergic agonists that act on muscarinic receptors can affect the GPCR signaling milieu, which could indirectly influence GPR82's function.

SEE ALSO...

Items 11 to 11 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Levodopa

59-92-7sc-205372
sc-205372A
5 g
25 g
$53.00
$168.00
9
(1)

A precursor to dopamine, which acts on dopamine receptors that are GPCRs. The increase in dopamine can alter GPCR signaling and potentially lead to enhanced activity of GPR82.